Molecular Evaluation of NSCLC Tissue Samples
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

Molecular Evaluation of NSCLC Tissue Samples

Sponsor: Amgen Inc.

Protocol 20190294. A Non-interventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Non-Small Cell Lung Cancer (NSCLC). Collection of tumor tissue and testing for KRAS G12C mutation for consideration of future enrollment into an international trial.